References
- Amori N, Aghajani M, Asgarian F, Jazayeri M. Epidemiology and trend of common cancers in Iran (2004–2008). Eur J Cancer Care. 2017;26(5):e12449. doi:https://doi.org/10.1111/ecc.
- Center M, Siegel R, Jemal A. Global cancer facts & figures. Atlanta: American Cancer Society; 2011. 1–52 p.
- Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386. doi:https://doi.org/10.1002/ijc.33588.
- Keyghobadi N, Rafiemanesh H, Mohammadian-Hafshejani A, Enayatrad M, Salehiniya H. Epidemiology and trend of cancers in the province of Kerman: southeast of Iran. Asian Pac J Cancer Prev. 2015;16(4):1409–1413. doi:https://doi.org/10.7314/APJCP.2015.16.4.1409.
- Kimberly DM, Rebecca LS, Chun CL, Angela BM, Joan LK, Julia HR, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271–289. doi:https://doi.org/10.3322/caac.21349.
- Jean CY, Syrjala KL. Anxiety and depression in cancer survivors. Med Clin North Am. 2017;101(6):1099–1113. doi:https://doi.org/10.16/j.mcna.2017.06.005.
- Marzorati C, Riva S, Pravettoni G. Who is a cancer survivor? A systematic review of published definitions. J Cancer Educ. 2017;32(2):228–237. doi:https://doi.org/10.1007/s13187-016-0997-2.
- McDonnell GA, Salley CG, Barnett M, DeRosa AP, Werk RS, Hourani A, et al. Anxiety among adolescent survivors of pediatric cancer. J Adolesc Health. 2017;61(4):409–423. doi:https://doi.org/10.1016/j.jadohealth.2017.04.004.
- Fitch MI, Nicoll I, Lockwood G. Cancer survivor's perspectives on the major challenge in the transition to survivorship. Patient Educ Couns. 2020;103(11):2361–2367. doi:https://doi.org/10.1016/j.pec.2020.04.018.
- Hong SJ, Shin N-M, Jung S. A predictive model of fear of cancer recurrence for patients undergoing chemotherapy. Support Care Cancer. 2020;28(9):4173–4181. doi:https://doi.org/10.1007/s00520-019-5245-7.
- Zakeri MA, Dehghan M, Ghaedi-Heidari F, Zakeri M, Bazmandegan G. Chronic patients’ activation and its association with stress, anxiety, depression, and quality of life: a survey in Southeast Iran. BioMed Res Int. 2021;2021:1–8. doi:https://doi.org/10.1155/2021/.
- Kwakkenbos L, van Lankveld WG, Vonk MC, Becker ES, van den Hoogen FH, van den Ende CH. Disease-related and psychosocial factors associated with depressive symptoms in patients with systemic sclerosis, including fear of progression and appearance self-esteem. J Psychosom Res. 2012;72(3):199–204. doi:https://doi.org/10.1016/j.jpsychores.2011.12.005.
- Reed SC, Bell JF, Miglioretti DL, Nekhlyudov L, Fairman N, Joseph JG. Relationships between fear of cancer recurrence and lifestyle factors among cancer survivors. J Cancer Educ. 2020;35(4):669–677. doi:https://doi.org/10.1007/s13187-019-01509-2.
- Smith AB, Costa D, Galica J, Lebel S, Tauber N, van Helmondt SJ, et al. Spotlight on the fear of cancer recurrence inventory (FCRI). Psychol Res Behav Manag. 2020;13:1257–1268. doi:https://doi.org/10.2147/PRBM.S231577.
- Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;7(3):300–322. doi:https://doi.org/10.1007/s11764-013-0272-z.
- Hopman P, Rijken M. Illness perceptions of cancer patients: relationships with illness characteristics and coping. Psychooncology. 2015;24(1):11–18. doi:https://doi.org/10.1002/pon.3591.
- Freeman‐Gibb LA, Janz NK, Katapodi MC, Zikmund‐Fisher BJ, Northouse L. The relationship between illness representations, risk perception and fear of cancer recurrence in breast cancer survivors. Psychooncology. 2017;26(9):1270–1277. doi:https://doi.org/10.002/pon.4143.
- Kangas M, Henry JL, Bryant RA. Posttraumatic stress disorder following cancer: a conceptual and empirical review. Clin Psychol Rev. 2002;22(4):499–524. doi:https://doi.org/10.1016/S0272-7358(01)00118-0.
- Craske MG, Rauch SL, Ursano R, Prenoveau J, Pine DS, Zinbarg RE. What is an anxiety disorder? FOC. 2011;9(3):369–388. doi:https://doi.org/10.1176/foc.9.3.foc369.
- Yan R, Xia J, Yang R, Lv B, Wu P, Chen W, et al. Association between anxiety, depression, and comorbid chronic diseases among cancer survivors. Psychooncology. 2019;28(6):1269–1277. doi:https://doi.org/10.002/pon.5078.
- To KK-W, Tsang OT-Y, Yip CC-Y, Chan K-H, Wu T-C, Chan JM-C, et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis. 2020;71(15):841–843. doi:https://doi.org/10.1093/cid/ciaa149.
- Ornell F, Schuch JB, Sordi AO, Kessler FHP. Pandemic fear” and COVID-19: mental health burden and strategies. Braz J Psychiatry. 2020;42(3):232–235. doi:https://doi.org/10.1590/16-4446-2020-0008.
- Sun P, Qie S, Liu Z, Ren J, Li K, Xi J. Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: a single arm meta-analysis. J Med Virol. 2020;92(6):612–617. doi:https://doi.org/10.1002/jmv.25735.
- Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433. doi:https://doi.org/10.1016/j.jaut.2020.
- Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A, *Brescia Renal COVID Task Force, et al. Management of patients on dialysis and with kidney transplantation during the SARS-CoV-2 (COVID-19) pandemic in Brescia, Italy. Kidney Int Rep. 2020;5(5):580–585. doi:https://doi.org/10.1016/j.ekir.2020.04.001.
- Cai Y, Xu Y, Xu D, Wang Y, Wang X, Sun C, et al. Considerations in treating patients with advance lung cancer during the epidemic outbreak of novel coronavirus (SARS-CoV-2). Med Oncol. 2020;37(9):1–5. doi:https://doi.org/10.1007/s12032-020-01401-w.
- Baddour K, Kudrick LD, Neopaney A, Sabik LM, Peddada SD, Nilsen ML, et al. Potential impact of the COVID-19 pandemic on financial toxicity in cancer survivors. Head Neck. 2020;42(6):1332–1338. doi:https://doi.org/10.002/hed.26187.
- Zakeri MA, Hr SM, Kahnooji M, Dehghan M. Generalized anxiety disorder during the COVID-19 outbreak in Iran: the role of social dysfunction. J Nerv Ment Dis. 2021;209:491–496. doi:https://doi.org/10.1097/nmd.0000000000001320.
- Bajema KL, Oster AM, McGovern OL, Lindstrom S, Stenger MR, Anderson TC, 2019-CoV Persons Under Investigation Team, et al. Persons evaluated for 2019 novel Coronavirus – United States, January 2020. MMWR Morb Mortal Wkly Rep. 2020;69(6):166–170. doi:https://doi.org/10.15585/mmwr.mm6906e1.
- Zakeri MA, Dehghan M. The impact of the COVID-19 disease on the referral and admission of the non-COVID-19 patients. Int J Health Plann Manage. 2021;36(1):209–211. doi:https://doi.org/10.1002/hpm.3060.
- Boyes AW, Girgis A, D'Este C, Zucca AC. Flourishing or floundering? Prevalence and correlates of anxiety and depression among a population-based sample of adult cancer survivors 6months after diagnosis. J Affect Disord. 2011;135(1–3):184–192. doi:https://doi.org/10.1016/j.jad.2011.07.016.
- Dehghan M, Namjoo Z, Zarei A, Tajedini H, Bahrami A, Zakeri MA. The relationship between coronavirus anxiety, mindfulness and spiritual health in patients with cancer: a survey in Southeast Iran. Psychiatry Investig. 2021;18(5):443–452. doi:https://doi.org/10.30773/pi.2020.0441.
- De Joode K, Dumoulin D, Engelen V, Bloemendal H, Verheij M, van Laarhoven H, et al. Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients' perspective. Eur J Cancer. 2020;136:132–139. doi:https://doi.org/10.1016/j.ejca.2020.06.019.
- Amatoury M, Maguire AM, Olivier J, Barton B, Gabriel M, Dalla-Pozza L, et al. Salivary cortisol reveals overt and hidden anxiety in survivors of childhood cancer attending clinic. J Affect Disord. 2018;240:105–112. doi:https://doi.org/10.1016/j.jad.2018.07.035.
- Sigorski D, Sobczuk P, Osmola M, Kuć K, Walerzak A, Wilk M, et al. Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy. ESMO Open. 2020;5(5):e000970. doi:https://doi.org/10.1136/esmoopen-2020-.
- Chen G, Wu Q, Jiang H, Zhang H, Peng J, Hu J, et al. Fear of disease progression and psychological stress in cancer patients under the outbreak of COVID-19. Psychooncology. 2020;29(9):1395–1398. doi:https://doi.org/10.002/pon.5451.
- Simard S, Savard J. Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009;17(3):241–251. doi:https://doi.org/10.1007/s00520-008-0444-y.
- Bateni FS, Rahmatian M, Kaviani A, Simard S, Soleimani M, Nejatisafa A. The Persian version of the fear of cancer recurrence inventory (FCRI): translation and evaluation of its psychometric properties. Arch Breast Cancer. 2019;2019:174–180. doi:https://doi.org/10.32768/abc.201964174-180.
- Alipour A, Ghadami A, Alipour Z, Abdollahzadeh H. Preliminary validation of the Corona Disease Anxiety Scale (CDAS) in the Iranian sample. Q J Health Psychol. 2020;8(32):163–175. doi:https://doi.org/10.30473/hpj.2020.52023.4756.
- Thewes B, Kaal SE, Custers JA, Manten-Horst E, Jansen R, Servaes P, et al. Prevalence and correlates of high fear of cancer recurrence in late adolescents and young adults consulting a specialist adolescent and young adult (AYA) cancer service. Support Care Cancer. 2018;26(5):1479–1487. doi:https://doi.org/10.007/s00520-017-3975-2.
- Kim SY, Kim S. Do COVID-19-related treatment changes influence fear of cancer recurrence, anxiety, and depression in breast cancer patients? Cancer Nurs. 2022;45(2):E628–E638. doi:https://doi.org/10.1097/NCC.0000000000000937.
- Cho D, Park CL. Moderating effects of perceived growth on the association between fear of cancer recurrence and health-related quality of life among adolescent and young adult cancer survivors. J Psychosoc Oncol. 2017;35(2):148–165. doi:https://doi.org/10.1080/07347332.2016.1247408.
- Mattsson E, Einhorn K, Ljungman L, Sundström-Poromaa I, Stålberg K, Wikman A. Women treated for gynaecological cancer during young adulthood – a mixed-methods study of perceived psychological distress and experiences of support from health care following end-of-treatment. Gynecol Oncol. 2018;149(3):464–469. doi:https://doi.org/10.1016/j.ygyno.2018.03.055.
- Yang Y, Li W, Wen Y, Wang H, Sun H, Liang W, et al. Fear of cancer recurrence in adolescent and young adult cancer survivors: a systematic review of the literature. Psychooncology. 2019;28(4):675–686. doi:https://doi.org/10.1002/pon.5013.
- Fardell JE, Jones G, Smith AB, Lebel S, Thewes B, Costa D, Conquer Fear Authorship Group, et al. Exploring the screening capacity of the Fear of Cancer Recurrence Inventory-Short Form for clinical levels of fear of cancer recurrence. Psychooncology. 2018;27(2):492–499. doi:https://doi.org/10.1002/pon.4516.
- McGinty HL, Small BJ, Laronga C, Jacobsen PB. Predictors and patterns of fear of cancer recurrence in breast cancer survivors. Health Psychol. 2016;35(1):1–9. doi:https://doi.org/10.1037/hea0000238.
- Tauber NM, O’Toole MS, Dinkel A, Galica J, Humphris G, Lebel S, et al. Effect of psychological intervention on fear of cancer recurrence: a systematic review and meta-analysis. JCO. 2019;37(31):2899–2915. doi:https://doi.org/10.1200/JCO.19.00572.
- Lebel S, Mutsaers B, Tomei C, Leclair CS, Jones G, Petricone-Westwood D, et al. Health anxiety and illness-related fears across diverse chronic illnesses: a systematic review on conceptualization, measurement, prevalence, course, and correlates. PLOS One. 2020;15(7):e0234124. doi:https://doi.org/10.1371/journal.pone.
- Fardell JE, Thewes B, Turner J, Gilchrist J, Sharpe L, Smith AB, et al. Fear of cancer recurrence: a theoretical review and novel cognitive processing formulation. J Cancer Surviv. 2016;10(4):663–673. doi:https://doi.org/10.1007/s11764-015-0512-5.
- Ayubi E, Bashirian S, Khazaei S. Depression and anxiety among patients with cancer during COVID-19 pandemic: a systematic review and meta-analysis. J Gastrointest Cancer. 2021;52(2):499–507. doi:https://doi.org/10.1007/s12029-021-00643-9.
- Francescangeli F, De Angelis ML, Zeuner A. COVID-19: a potential driver of immune-mediated breast cancer recurrence? Breast Cancer Res. 2020;22(1):1–3. doi:https://doi.org/10.1186/s13058-020-01360-0.
- Liu J, Peh C-X, Simard S, Griva K, Mahendran R. Beyond the fear that lingers: the interaction between fear of cancer recurrence and rumination in relation to depression and anxiety symptoms. J Psychosom Res. 2018;111:120–126. doi:https://doi.org/10.1016/j.jpsychores.2018.06.004.
- Curran L, Sharpe L, MacCann C, Butow P. Testing a model of fear of cancer recurrence or progression: the central role of intrusions, death anxiety and threat appraisal. J Behav Med. 2020;43(2):225–236. doi:https://doi.org/10.1007/s10865-019-00129-x.
- Thewes B, Bell ML, Butow P, Beith J, Boyle F, Friedlander M, *Members of the FCR Study Advisory Committee, et al. Psychological morbidity and stress but not social factors influence level of fear of cancer recurrence in young women with early breast cancer: results of a cross-sectional study. Psychooncology. 2013;22(12):2797–2806. doi:https://doi.org/10.1002/pon.3348.
- Yang Y, Sun H, Luo X, Li W, Yang F, Xu W, et al. Network connectivity between fear of cancer recurrence, anxiety, and depression in breast cancer patients. J Affect Disord. 2022;309:358–367. doi:https://doi.org/10.1016/j.jad.2022.04.119.
- Malakoutikhah A, Zakeri MA, Salehi Derakhtanjani A, Dehghan M. Anxiety, anger, and mindfulness as predictors of general health in the general population during COVID‐19 outbreak: a survey in southeast Iran. J Community Psychol. 2022;50(2):916–927. doi:https://doi.org/10.1002/jcop.22690.
- Zakeri MA, Rafsanjanipoor SMH, Sedri N, Kahnooji M, Rafsanjani MS, Zakeri M, et al. Psychosocial status during the prevalence of COVID-19 disease: the comparison between healthcare workers and general population. Curr Psychol. 2021;40(12):6324–6329. doi:https://doi.org/10.1007/s12144-021-01582-1.
- Zakeri MA, Maazallahi M, Ehsani V, Dehghan M. Iranian psychosocial status during and after COVID-19 outbreak mandatory quarantine: a cross-sectional study. J Community Psychol. 2021;49(7):2506–2516. doi:https://doi.org/10.1002/jcop.22647.
- Hossini Rafsanjanipoor SM, Zakeri MA, Dehghan M, Kahnooji M, Sanji Rafsanjani M, Ahmadinia H, et al. Iranian psychosocial status and its determinant factors during the prevalence of COVID-19 disease. Psychol Health Med. 2022;27(1):30–41. doi:https://doi.org/10.1080/13548506.2021.1874438.
- Reinfjell T, Tremolada M, Zeltzer LK. A review of demographic, medical, and treatment variables associated with health-related quality of life (HRQOL) in survivors of hematopoietic stem cell (HSCT) and bone marrow transplantation (BMT) during childhood. Front Psychol. 2017;8:253. doi:https://doi.org/10.3389/fpsyg.2017.00253.
- Dehghan M, Jazinizade M, Malakoutikhah A, Madadimahani A, Iranmanesh MH, Oghabian S, et al. Stress and quality of life of patients with cancer: the mediating role of mindfulness. J Oncol. 2020;2020:1–10. doi:https://doi.org/10.1155/2020/3289521.
- Yang Y, Cameron J, Humphris G. The relationship between cancer patient's fear of recurrence and radiotherapy: a systematic review and meta‐analysis. Psycho‐oncology. 2017;26(6):738–746. doi:https://doi.org/10.1002/pon.4224.
- Yang Y, Humphris G, Sun H, Li W, Hao Y, Liu T, et al. Psychometric properties of the Chinese version Fear of Cancer Recurrence Questionnaire-7 (FCR-7). Prof Psychol: Res Pract. 2019;50(6):376–383. doi:https://doi.org/10.1037/pro0000257.
- Ramadas A, Qureshi AM, Dominic NA, Botross NP, Riad A, Arasoo VJT, et al. Socio-demography and medical history as predictors of health-related quality of life of breast cancer survivors. Asian Pac J Cancer Prev. 2015;16(4):1479–1485. doi:https://doi.org/10.7314/APJCP.2015.16.4.1479.
- Sun H, Yang Y, Zhang J, Liu T, Wang H, Garg S, et al. Fear of cancer recurrence, anxiety and depressive symptoms in adolescent and young adult cancer patients. Neuropsychiatr Dis Treat. 2019;15:857–865. doi:https://doi.org/10.2147/NDT.S202432.
- Lebel S, Beattie S, Arès I, Bielajew C. Young and worried: age and fear of recurrence in breast cancer survivors. Health Psychol. 2013;32(6):695–705. doi:https://doi.org/10.1037/a0030186.
- Yang Y, Sun H, Liu T, Zhang J, Wang H, Liang W, et al. Factors associated with fear of progression in chinese cancer patients: sociodemographic, clinical and psychological variables. J Psychosom Res. 2018;114:18–24. doi:https://doi.org/10.1016/j.jpsychores.2018.09.003.